Lilly discovers social media

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. launched its own blog this month, dubbed LillyPad, to try to start discussions about public policy and corporate social responsibility. The Indianapolis-based drugmaker also launched an accompanying Twitter feed.

“Policy issues like health care reform have been top-of-mind with the public for a long time. And industry watchers are placing an increased premium on trends like corporate citizenship. These are important dialogues, and we’re happy to provide a forum and participate,” wrote Lilly spokesman Greg Kueterman, in a Sept. 14 post.

Others who have posted so far include Amy O’Connor, a Lilly lobbyist in Washington, and Rob Smith, director of Lilly’s charitable foundation.

The new blog received both kudos and criticism from Rich Meyer, a Lilly alumnus who now works as a marketing consultant.

“Lilly needs to set clear and concise objectives for this blog,” Meyer wrote on his own blog, World of DTC Marketing.com. “Right now I’m not sure who the target audience is supposed to be, but if they are trying to reach customers and patients they are going to have to be a lot more open, direct and personable.”

His suggestions? Get Lilly CEO John Lechleiter blogging frequently about Lilly’s business and health care issues. Have the brand leaders of each Lilly drug blog too, he said. And lastly, Meyer said, “Get rid of corporate speak.”

For a company as highly regulated and litigation-prone as Lilly is, that’s probably far easier said than done.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ